72
Participants
Start Date
February 28, 2011
Primary Completion Date
May 31, 2013
Study Completion Date
August 31, 2013
HYNR-CS inj
Intrathecal injection with 1ml/10kg of body weight at an interval of 26 days.
Control group
No treatment of HYNR-CS inj
Hanyang University Hospital, Seoul
Lead Sponsor
Corestemchemon, Inc.
INDUSTRY